ADMS - Adamas Pharma EPS misses by $0.14 beats on revenue February, 23 2021 04:36 PM Adamas Pharmaceuticals Inc. Adamas Pharma (ADMS): Q4 GAAP EPS of -$0.64 misses by $0.14.Revenue of $21M (+28.4% Y/Y) beats by $0.35M.Press Release For further details see: Adamas Pharma EPS misses by $0.14, beats on revenue